Keyphrases
Chronic Kidney Disease
50%
Kazakhstan
50%
Dialysis Treatment
31%
Electronic Health Systems
31%
Kidney Transplantation
27%
Health Registries
25%
Intravenous Immunoglobulin (IVIg)
25%
Rituximab
25%
Chronic Antibody-mediated Rejection
25%
Renal Transplant Recipients
25%
Disease Therapy
25%
Acute Kidney Injury
25%
Kidney Dialysis
25%
Combination Therapy
25%
Epidemiology
25%
Dialysis Patients
25%
Dialysis
25%
End-stage Renal Disease Patients
25%
Late Diagnosis
25%
Renal Replacement Therapy
25%
Pediatric Nephrology
25%
Mortality Rate
18%
End-stage Renal Disease
15%
Survival Probability
15%
Kazakh
12%
Risk of Death
12%
Prevalence Rate
12%
Older Patients
12%
High Risk
12%
Incidence Rate
12%
Confidence Interval
12%
Young Ones
12%
Therapy Initiation
10%
Kazakh Population
8%
Comorbidity
8%
Estimated Glomerular Filtration Rate
7%
National Population
6%
Population-based Registry
6%
Registry Data
6%
Countries in Transition
6%
Economies in Transition
6%
Hemodialysis
6%
Descriptive Statistics
6%
Administrative Healthcare Data
6%
Overall Mortality
6%
Maintenance Dialysis
6%
Peritoneal Dialysis
6%
Developing Countries
6%
Developing Economies
6%
Non-responders
5%
INIS
kidneys
100%
therapy
60%
diseases
58%
kazakhstan
50%
patients
39%
dialysis
33%
data
27%
transplants
25%
antibodies
25%
immunoglobulins
25%
epidemiology
25%
comparative evaluations
16%
filtration
9%
injuries
8%
pediatrics
8%
males
7%
populations
5%
mortality
5%
females
5%
probability
5%
Medicine and Dentistry
Renal Replacement Therapy
58%
Chronic Kidney Disease
50%
Combination Therapy
50%
End Stage Renal Disease
27%
Kidney Transplantation
27%
Cohort Effect
25%
Rituximab
25%
Antibody Mediated Rejection
25%
Kidney Graft
25%
Immunoglobulin
25%
Mortality Rate
25%
Prevalence
25%
Acute Kidney Injury
25%
Kidney Dialysis
25%
Pediatric Nephrology
25%
Survival Rate
16%
Health System
13%
Glomerular Filtration Rate
9%
Peritoneal Dialysis
8%
Hemodialysis
8%
Diagnosis
5%
